Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Krenning

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel LevineRachel Levine, Eric P Krenning
Best Practice & Research. Clinical Endocrinology & Metabolism|June 19, 2007
The kinetics of thyroid hormone transporters and their role in non-thyroidal illness and starvationGeorg Hennemann, Eric P Krenning
Hematology/Oncology Clinics of North America|November 29, 2015
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine TumorsDik J Kwekkeboom, Eric P Krenning
Seminars in Nuclear Medicine|April 20, 2002
Somatostatin receptor imagingDik J Kwekkeboom, Eric P Krenning
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Candidates for peptide receptor radiotherapy today and in the futureJean Claude Reubi, Helmut R Mäcke, Eric P Krenning
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2012
Reduction of renal uptake of radiolabeled octreotate by amifostine coadministrationMarleen Melis, Roelf Valkema, Eric P Krenning, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2003
Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002Marion de Jong, Dik Kwekkeboom, Roelf Valkema, et al.
Pharmaceutics|August 26, 2023
Toward Stability Enhancement of NTS<sub>1</sub>R-Targeted Radioligands: Structural Interventions on [<sup>99m</sup>Tc]Tc-DT1Panagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotateJaap J M Teunissen, Dik J Kwekkeboom, Eric P Krenning
Trends in Endocrinology and Metabolism: TEM|November 29, 2005
Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogsJaap J M Teunissen, Dik J Kwekkeboom, Eric P Krenning
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel LevineRachel Levine, Eric P Krenning
Best Practice & Research. Clinical Endocrinology & Metabolism|June 19, 2007
The kinetics of thyroid hormone transporters and their role in non-thyroidal illness and starvationGeorg Hennemann, Eric P Krenning
Hematology/Oncology Clinics of North America|November 29, 2015
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine TumorsDik J Kwekkeboom, Eric P Krenning
Seminars in Nuclear Medicine|April 20, 2002
Somatostatin receptor imagingDik J Kwekkeboom, Eric P Krenning
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Candidates for peptide receptor radiotherapy today and in the futureJean Claude Reubi, Helmut R Mäcke, Eric P Krenning
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2012
Reduction of renal uptake of radiolabeled octreotate by amifostine coadministrationMarleen Melis, Roelf Valkema, Eric P Krenning, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2003
Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002Marion de Jong, Dik Kwekkeboom, Roelf Valkema, et al.
Pharmaceutics|August 26, 2023
Toward Stability Enhancement of NTS<sub>1</sub>R-Targeted Radioligands: Structural Interventions on [<sup>99m</sup>Tc]Tc-DT1Panagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotateJaap J M Teunissen, Dik J Kwekkeboom, Eric P Krenning
Trends in Endocrinology and Metabolism: TEM|November 29, 2005
Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogsJaap J M Teunissen, Dik J Kwekkeboom, Eric P Krenning
Pageof 18